{"id":386846,"date":"2016-08-12T00:00:00","date_gmt":"2016-08-12T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360rp0007-medtech-contrast-agents-and-radiopharmaceuticals-us-2016-market-analysis\/"},"modified":"2026-04-23T11:11:23","modified_gmt":"2026-04-23T11:11:23","slug":"m360rp0007-medtech-contrast-agents-and-radiopharmaceuticals-us-2016-market-analysis","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360rp0007-medtech-contrast-agents-and-radiopharmaceuticals-us-2016-market-analysis\/","title":{"rendered":"Contrast Agents and Radiopharmaceuticals | US | 2016 | Market Analysis"},"content":{"rendered":"<p><span>Growth<\/span> in the US market for contrast agents and radiopharmaceuticals will be driven by the <span>expanded<\/span> use of imaging agents in <abbr title=\"Contrast-Enhanced Ultrasound\">CEUS<\/abbr> and <abbr title=\"Positron Emission Tomography\">PET<\/abbr> procedures. However, the market will be somewhat limited by uncertainty surrounding the health impacts of gadolinium and radiation exposure in certain modalities, while the shift to value-based care will hinder the use of some procedures while supporting the use of those that provide the most accuracy and clarity of visualization.\u00a0<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for contrast agents and radiopharmaceuticals in the US across a 10-year period.<\/p>\n","protected":false},"template":"","class_list":["post-386846","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-contrast-agents-and-radiopharmaceuticals","medtech-date-857"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386846","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386846\/revisions"}],"predecessor-version":[{"id":388342,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386846\/revisions\/388342"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=386846"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}